Total Liabilities Summary of AstraZeneca PLC

AstraZeneca PLC's latest annual total liabilities in 2023 was 61.95 Billion USD , up 4.25% from previous year.
AstraZeneca PLC's latest quarterly total liabilities in 2024 Q1 was 64.79 Billion USD , up 4.58% from previous quarter.
AstraZeneca PLC reported annual total liabilities of 59.42 Billion USD in 2022, down -10.07% from previous year.
AstraZeneca PLC reported annual total liabilities of 66.07 Billion USD in 2021, up 29.33% from previous year.
AstraZeneca PLC reported quarterly total liabilities of 64.79 Billion USD for 2024 Q1, up 4.58% from previous quarter.
AstraZeneca PLC reported quarterly total liabilities of 59.12 Billion USD for 2023 Q2, down -2.87% from previous quarter.

Annual Total Liabilities Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Total Liabilities of AstraZeneca PLC (2023 - 1990)

Year	Total Liabilities	Total Liabilities Growth
2023	61.95 Billion USD	4.25%
2022	59.42 Billion USD	-10.07%
2021	66.07 Billion USD	29.33%
2020	51.09 Billion USD	9.21%
2019	46.78 Billion USD	0.37%
2018	46.6 Billion USD	-0.22%
2017	46.71 Billion USD	1.86%
2016	45.85 Billion USD	10.19%
2015	41.61 Billion USD	6.84%
2014	38.94 Billion USD	19.31%
2013	32.64 Billion USD	10.36%
2012	29.58 Billion USD	0.76%
2011	29.35 Billion USD	-10.27%
2010	32.71 Billion USD	-4.05%
2009	34.09 Billion USD	10.39%
2008	30.89 Billion USD	-6.51%
2007	33.04 Billion USD	127.62%
2006	14.51 Billion USD	30.2%
2005	11.14 Billion USD	-0.05%
2004	11.15 Billion USD	8.13%
2003	10.31 Billion USD	-0.38%
2002	10.35 Billion USD	-18.35%
2001	12.68 Billion USD	42.54%
2000	8.89 Billion USD	-6.04%
1999	9.46 Billion USD	99.19%
1998	4.75 Billion USD	2.05%
1997	4.65 Billion USD	-4.95%
1996	4.9 Billion USD	1.4%
1995	4.83 Billion USD	5.23%
1994	4.59 Billion USD	-9.94%
1993	5.1 Billion USD	-15.25%
1992	6.01 Billion USD	10.52%
1991	5.44 Billion USD	0.49%
1990	5.41 Billion USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	64.74 Billion USD	-0.08%
2024 Q1	64.79 Billion USD	4.58%
2023 Q2	59.12 Billion USD	-2.87%
2023 Q1	60.87 Billion USD	2.44%
2023 Q3	58.86 Billion USD	-0.44%
2023 Q4	61.95 Billion USD	5.25%
2023 FY	61.95 Billion USD	4.25%
2022 Q3	59.03 Billion USD	-2.63%
2022 Q4	59.42 Billion USD	0.67%
2022 Q1	63.91 Billion USD	-3.27%
2022 FY	59.42 Billion USD	-10.07%
2022 Q2	60.62 Billion USD	-5.14%
2021 Q2	57.94 Billion USD	14.79%
2021 Q4	66.07 Billion USD	-1.83%
2021 FY	66.07 Billion USD	29.33%
2021 Q3	67.3 Billion USD	16.15%
2021 Q1	50.48 Billion USD	-1.2%
2020 Q1	44.99 Billion USD	-3.82%
2020 FY	51.09 Billion USD	9.21%
2020 Q4	51.09 Billion USD	1.18%
2020 Q3	50.49 Billion USD	9.13%
2020 Q2	46.27 Billion USD	2.84%
2019 Q3	45.23 Billion USD	-3.38%
2019 Q2	46.81 Billion USD	-4.5%
2019 FY	46.78 Billion USD	0.37%
2019 Q1	49.02 Billion USD	5.19%
2019 Q4	46.78 Billion USD	3.41%
2018 FY	46.6 Billion USD	-0.22%
2018 Q2	47.07 Billion USD	-3.36%
2018 Q3	47.9 Billion USD	1.77%
2018 Q1	48.7 Billion USD	4.27%
2018 Q4	46.6 Billion USD	-2.71%
2017 Q1	46.18 Billion USD	0.7%
2017 Q4	46.71 Billion USD	-4.94%
2017 Q2	49.7 Billion USD	7.64%
2017 Q3	49.14 Billion USD	-1.14%
2017 FY	46.71 Billion USD	1.86%
2016 Q1	47.68 Billion USD	14.58%
2016 Q4	45.85 Billion USD	-5.08%
2016 Q2	49.02 Billion USD	2.83%
2016 FY	45.85 Billion USD	10.19%
2016 Q3	48.31 Billion USD	-1.47%
2015 FY	41.61 Billion USD	6.84%
2015 Q1	36.74 Billion USD	-5.66%
2015 Q3	36.75 Billion USD	-0.33%
2015 Q4	41.61 Billion USD	13.24%
2015 Q2	36.87 Billion USD	0.34%
2014 Q2	36.48 Billion USD	-3.76%
2014 Q3	35.69 Billion USD	-2.16%
2014 Q4	38.94 Billion USD	9.11%
2014 FY	38.94 Billion USD	19.31%
2014 Q1	37.91 Billion USD	16.13%
2013 Q1	29.84 Billion USD	0.88%
2013 Q3	30.67 Billion USD	0.32%
2013 Q4	32.64 Billion USD	6.43%
2013 FY	32.64 Billion USD	10.36%
2013 Q2	30.57 Billion USD	2.46%
2012 Q3	30.18 Billion USD	3.56%
2012 Q4	29.58 Billion USD	-2.0%
2012 Q1	29.04 Billion USD	-1.08%
2012 FY	29.58 Billion USD	0.76%
2012 Q2	29.15 Billion USD	0.37%
2011 Q3	28.42 Billion USD	-3.95%
2011 Q4	29.35 Billion USD	3.29%
2011 FY	29.35 Billion USD	-10.27%
2011 Q1	31.98 Billion USD	-2.23%
2011 Q2	29.59 Billion USD	-7.49%
2010 Q1	33.18 Billion USD	-2.67%
2010 FY	32.71 Billion USD	-4.05%
2010 Q4	32.71 Billion USD	-3.99%
2010 Q3	34.07 Billion USD	5.24%
2010 Q2	32.38 Billion USD	-2.43%
2009 FY	34.09 Billion USD	10.39%
2009 Q4	34.09 Billion USD	5.42%
2009 Q3	32.34 Billion USD	0.27%
2009 Q2	32.25 Billion USD	4.11%
2009 Q1	30.98 Billion USD	0.85%
2008 Q1	33.59 Billion USD	1.66%
2008 FY	30.89 Billion USD	-6.51%
2008 Q2	34.1 Billion USD	1.54%
2008 Q3	31.97 Billion USD	-6.26%
2008 Q4	30.72 Billion USD	-3.9%
2007 Q1	15.54 Billion USD	7.07%
2007 FY	33.04 Billion USD	127.62%
2007 Q2	32.63 Billion USD	109.95%
2007 Q3	31.2 Billion USD	-4.37%
2007 Q4	33.04 Billion USD	5.88%
2006 Q3	13.33 Billion USD	-0.83%
2006 FY	14.51 Billion USD	30.2%
2006 Q4	14.51 Billion USD	8.82%
2006 Q1	14.51 Billion USD	30.2%
2006 Q2	13.45 Billion USD	-7.34%
2005 FY	11.14 Billion USD	-0.05%
2005 Q1	11.14 Billion USD	0.47%
2005 Q2	11.31 Billion USD	1.48%
2005 Q3	11.15 Billion USD	-1.38%
2005 Q4	11.14 Billion USD	-0.08%
2004 Q3	9.55 Billion USD	-17.23%
2004 Q2	11.54 Billion USD	1.5%
2004 FY	11.15 Billion USD	8.13%
2004 Q1	11.37 Billion USD	10.22%
2004 Q4	11.09 Billion USD	16.17%
2003 Q3	9.48 Billion USD	0.78%
2003 FY	10.31 Billion USD	-0.38%
2003 Q4	10.31 Billion USD	8.72%
2003 Q2	9.41 Billion USD	-9.1%
2003 Q1	10.35 Billion USD	0.08%
2002 Q2	9.21 Billion USD	-3.0%
2002 Q3	8.98 Billion USD	-2.48%
2002 FY	10.35 Billion USD	-18.35%
2002 Q4	10.35 Billion USD	15.21%
2002 Q1	9.49 Billion USD	-25.13%
2001 Q4	12.68 Billion USD	39.16%
2001 Q1	9.54 Billion USD	7.27%
2001 Q2	8.89 Billion USD	-6.8%
2001 Q3	9.11 Billion USD	2.46%
2001 FY	12.68 Billion USD	42.54%
2000 FY	8.89 Billion USD	-6.04%
2000 Q1	8.88 Billion USD	-6.22%
2000 Q2	9.27 Billion USD	4.49%
2000 Q3	9.6 Billion USD	3.49%
2000 Q4	8.89 Billion USD	-7.35%
1999 Q2	8.43 Billion USD	0.0%
1999 Q3	8.62 Billion USD	2.29%
1999 Q4	9.46 Billion USD	9.76%
1999 FY	9.46 Billion USD	99.19%
1998 Q2	4.8 Billion USD	0.0%
1998 FY	4.75 Billion USD	2.05%
1998 Q4	4.75 Billion USD	0.0%
1997 FY	4.65 Billion USD	-4.95%
1997 Q4	4.65 Billion USD	0.0%
1996 FY	4.9 Billion USD	1.4%
1996 Q4	4.9 Billion USD	0.0%
1995 Q4	4.83 Billion USD	0.0%
1995 Q2	4.71 Billion USD	0.0%
1995 FY	4.83 Billion USD	5.23%
1994 Q4	4.59 Billion USD	0.0%
1994 FY	4.59 Billion USD	-9.94%
1993 Q4	5.1 Billion USD	0.0%
1993 FY	5.1 Billion USD	-15.25%
1992 FY	6.01 Billion USD	10.52%
1991 FY	5.44 Billion USD	0.49%
1990 FY	5.41 Billion USD	0.0%

Peer Total Liabilities Comparison of AstraZeneca PLC

Name	Total Liabilities	Total Liabilities Difference
Amgen Inc.	90.92 Billion USD	31.861%
Biogen Inc.	12.04 Billion USD	-414.329%
Gilead Sciences, Inc.	39.37 Billion USD	-57.337%
MIRA Pharmaceuticals, Inc.	558.09 Thousand USD	-11100658.47%
Scilex Holding Company	274.24 Million USD	-22490.22%
Scilex Holding Company	274.24 Million USD	-22490.22%

Global Stocks Search

AstraZeneca PLC (AZN)

Total Liabilities Summary of AstraZeneca PLC

Annual Total Liabilities Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Total Liabilities of AstraZeneca PLC (2023 - 1990)

Peer Total Liabilities Comparison of AstraZeneca PLC